服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Type | Clone No |
| Anti-MAPT mAbs [Semorinemab Biosimilar] (MABL-5215) | MABL-5215 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD4 mAbs [Semzuvolimab Biosimilar] (MABL-5216) | MABL-5216 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TRBV9 mAbs [Seniprutug Biosimilar] (MABL-5217) | MABL-5217 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Serclutamab Biosimilar] (MABL-5218) | MABL-5218 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ERBB3/HER3 mAbs [Seribantumab Biosimilar] (MABL-5219) | MABL-5219 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-PDCD1/CD279/PD1 mAbs [Serplulimab Biosimilar] (MABL-5220) | MABL-5220 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-Shiga Toxin Type 2 mAbs [Setoxaximab Biosimilar] (MABL-5221) | MABL-5221 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SOST mAbs [Setrusumab Biosimilar] (MABL-5222) | MABL-5222 | ELISA, FACS, Functional assay, in vivo binding | G2, Lambda |
| Anti-TNFSF13/CD256/APRIL mAbs [Sibeprenlimab Biosimilar] (MABL-5223) | MABL-5223 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IFNA1 mAbs [Sifalimumab Biosimilar] (MABL-5224) | MABL-5224 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ITGB6 mAbs [Sigvotatug Biosimilar] (MABL-5225) | MABL-5225 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Rabies Lyssavirus Glycoprotein G epitope III;Rabies Lyssavirus Glycoprotein G epitope I mAbs [S | MABL-5226 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-Clostridium tetani tetanus toxin (TeNT) mAbs [Siltartoxatug Biosimilar] (MABL-5227) | MABL-5227 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IL6 mAbs [Siltuximab Biosimilar] (MABL-5228) | MABL-5228 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Simaravibart Biosimilar] (MABL-5229) | MABL-5229 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-FAP mAbs [Simlukafusp Biosimilar] (MABL-5230) | MABL-5230 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-IAP/CD47;PDL1/CD274 mAbs [Simridarlimab Biosimilar] (MABL-5231) | MABL-5231 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;na |
| Anti-LOXL2 mAbs [Simtuzumab Biosimilar] (MABL-5232) | MABL-5232 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Sintilimab Biosimilar] (MABL-5233) | MABL-5233 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SARS-CoV-2 Spike RBD mAbs [Sipavibart Biosimilar] (MABL-5234) | MABL-5234 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn